J Breast Cancer.
2009 Jun;12(2):92-99. 10.4048/jbc.2009.12.2.92.
The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report
- Affiliations
-
- 1Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea. brcakorea@gmail.com
- 2Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
- 3Department of Surgery, College of Medicine, University of Ulsan and Asan Medical Center, Seoul, Korea.
- 4Department of Surgery, Soonchunhyang University Hospital, Seoul, Korea.
- 5Department of Radiation Oncology, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 6Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
- 7Department of Surgery, Korea University College of Medicine, Seoul, Korea.
- 8Medical Research Collaboration Center, Seoul National University College of Medicine, Seoul, Korea.
- 9Department of Surgery, Hallym University Sacred Heart Hospital, Anyang, Korea.
- 10Department of Surgery, Ajou University School of Medicine, Suwon, Korea.
- 11Department of Surgery, St Vincent's Hospital, the Catholic University of Korea, Suwon, Korea.
- 12Department of Surgery, Ewha Womans' University Mokdong Hospital, School of Medicine, Seoul, Korea.
- 13Department of Surgery, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 14Department of Surgery, Korea Institute of Radiology and Medical Science, Seoul, Korea.
- 15Korean Breast Cancer Society, Seoul, Korea. brcakorea@gmail.com
- KMID: 2175204
- DOI: http://doi.org/10.4048/jbc.2009.12.2.92
Abstract
-
PURPOSE: To estimate the cumulative risk till each age (penetrance) of breast and ovarian cancers among female family members with BRCA1 and BRCA2 mutation.
METHODS
Among the 61 BRCA1 mutation carriers in the 42 families and 47 BRCA2 mutation carriers in 31 families identified at 5 academic breast clinics, the probands were excluded to estimate the cumulative risk till each age of breast cancer in the Korean BRCA1 and BRCA2 carriers. Using Kaplan-Meier analyses, cumulative cancer risk estimates were determined.
RESULTS
By the age 70, the female breast cancer risk for the BRCA1 and BRCA2 mutation carriers was 72.1% (95% confidence interval [CI]=59.5% to 84.8%) and 66.3% (95% CI=41.2% to 91.5%), respectively, and the ovarian cancer risk was 24.6% (95% CI=0% to 50.3%) and 11.1% (95% CI=0% to 31.6%), respectively. The contralateral breast cancer risk at 5 years after primary breast cancer was estimated as 16.2% (95% CI=9.3% to 23.1%) for the 52 breast cancer patients with the BRCA1 mutation and 17.3% (95% CI=9.7% to 24.0%) for the 35 breast cancer patients with the BRCA2 mutation.
CONCLUSION
The penetrance of BRCA mutations in Korea is largely consistent with the previous studies on Western populations. However, the small number of the cases, the high proportions of probands in the study subjects, the short term follow-up, and large confidence intervals are the limitations of the current study. The Korean Hereditary Breast Cancer Study (KOHBRA Study) may definitely answer this question.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Frequency of BRCA1 and BRCA2 Germline Mutations Detected by Protein Truncation Test and Cumulative Risks of Breast and Ovarian Cancer among Mutation Carriers in Japanese Breast Cancer Families
- One Korean Patient with a Family History of BRCA1-associated Ovarian Cancer
- Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
- Germline Mutations and polymorphisms of BRCA1 and BRCA2 in Sporadic Ovarian Carcinoma
- Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer
